학술논문

A Randomized, Double-Blind, Biomarker-Selected, Phase II Clinical Trial of Maintenance Poly ADP-Ribose Polymerase Inhibition With Rucaparib Following Chemotherapy for Metastatic Urothelial Carcinoma.
Document Type
Article
Source
Journal of Clinical Oncology; Jan2023, Vol. 41 Issue 1, p54-64, 11p
Subject
Language
ISSN
0732183X